These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 29996709)

  • 1. Knowledge database assisted gene marker selection for chronic lymphocytic leukemia.
    Xiang X; Wang YP; Cao H; Zhang X
    J Int Med Res; 2018 Aug; 46(8):3358-3364. PubMed ID: 29996709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A curated target gene pool assisting disease prediction and patient-specific biomarker selection for lung squamous cell carcinoma.
    Huang B; Zhong N; Cao H; Yu G
    Oncol Lett; 2018 Oct; 16(4):5140-5146. PubMed ID: 30197682
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Curated Target Gene Pool Assisting Early Disease Prediction and Patient-Specific Treatment for Small Cell Lung Cancer.
    Dong Y; Cao H; Liang Z
    J Comput Biol; 2018 Jun; 25(6):576-585. PubMed ID: 29741913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sparse Representation-Based Patient-Specific Diagnosis and Treatment for Esophageal Squamous Cell Carcinoma.
    Huang B; Zhong N; Xia L; Yu G; Cao H
    Bull Math Biol; 2018 Aug; 80(8):2124-2136. PubMed ID: 29869044
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a global gene expression signature of B-chronic lymphocytic leukemia.
    Jelinek DF; Tschumper RC; Stolovitzky GA; Iturria SJ; Tu Y; Lepre J; Shah N; Kay NE
    Mol Cancer Res; 2003 Mar; 1(5):346-61. PubMed ID: 12651908
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of mutated IGHV3-23 genes in chronic lymphocytic leukemia identifies a disease subset with peculiar clinical and biological features.
    Bomben R; Dal-Bo M; Benedetti D; Capello D; Forconi F; Marconi D; Bertoni F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Luciano F; Sozzi E; Cattarossi I; Zucchetto A; Rossi FM; Bulian P; Zucca E; Nicoloso MS; Degan M; Marasca R; Efremov DG; Del Poeta G; Gaidano G; Gattei V
    Clin Cancer Res; 2010 Jan; 16(2):620-8. PubMed ID: 20068100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seven-gene expression panel distinguishing clonal expansions of pre-leukemic and chronic lymphocytic leukemia B cells from normal B lymphocytes.
    McCarthy BA; Yancopoulos S; Tipping M; Yan XJ; Wang XP; Bennett F; Li W; Lesser M; Paul S; Boyle E; Moreno C; Catera R; Messmer BT; Cutrona G; Ferrarini M; Kolitz JE; Allen SL; Rai KR; Rawstron AC; Chiorazzi N
    Immunol Res; 2015 Dec; 63(1-3):90-100. PubMed ID: 26318878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression feature of CD3, FcεRIγ, and Zap-70 in patients with chronic lymphocytic leukemia.
    Huang L; Chen S; Zha X; Yang L; Li B; Yu Z; Wang L; Li Y
    Hematology; 2012 Mar; 17(2):71-5. PubMed ID: 22664044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating multiple immunogenetic data sources for feature extraction and mining somatic hypermutation patterns: the case of "towards analysis" in chronic lymphocytic leukaemia.
    Kavakiotis I; Xochelli A; Agathangelidis A; Tsoumakas G; Maglaveras N; Stamatopoulos K; Hadzidimitriou A; Vlahavas I; Chouvarda I
    BMC Bioinformatics; 2016 Jun; 17 Suppl 5(Suppl 5):173. PubMed ID: 27295298
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Number of Overlapping AID Hotspots in Germline IGHV Genes Is Inversely Correlated with Mutation Frequency in Chronic Lymphocytic Leukemia.
    Yuan C; Chu CC; Yan XJ; Bagnara D; Chiorazzi N; MacCarthy T
    PLoS One; 2017; 12(1):e0167602. PubMed ID: 28125682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intragenic Variations in BTLA Gene Influence mRNA Expression of BTLA Gene in Chronic Lymphocytic Leukemia Patients and Confer Susceptibility to Chronic Lymphocytic Leukemia.
    Karabon L; Partyka A; Jasek M; Lech-Maranda E; Grzybowska-Izydorczyk O; Bojarska-Junak A; Pawlak-Adamska E; Tomkiewicz A; Robak T; Rolinski J; Frydecka I
    Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):137-145. PubMed ID: 27933341
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Exploring the nature of prediagnostic blood transcriptome markers of chronic lymphocytic leukemia by assessing their overlap with the transcriptome at the clinical stage.
    Vlaanderen J; Leenders M; Chadeau-Hyam M; Portengen L; Kyrtopoulos SA; Bergdahl IA; Johansson AS; Hebels DD; de Kok TM; Vineis P; Vermeulen RC
    BMC Genomics; 2017 Mar; 18(1):239. PubMed ID: 28320322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational status and gene repertoire of IGHV-IGHD-IGHJ rearrangements in Serbian patients with chronic lymphocytic leukemia.
    Karan-Djurasevic T; Palibrk V; Kostic T; Spasovski V; Nikcevic G; Srzentic S; Colovic M; Colovic N; Vidovic A; Antic D; Mihaljevic B; Pavlovic S; Tosic N
    Clin Lymphoma Myeloma Leuk; 2012 Aug; 12(4):252-60. PubMed ID: 22560084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrimination of chronic lymphocytic leukemia (CLL) and CLL/PL by cytomorphology can clearly be correlated to specific genetic markers as investigated by interphase fluorescence in situ hybridization (FISH).
    Bacher U; Kern W; Schoch C; Hiddemann W; Haferlach T
    Ann Hematol; 2004 Jun; 83(6):349-55. PubMed ID: 15034762
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Integrative Computational Approach to Evaluate Genetic Markers for Chronic Lymphocytic Leukemia.
    Zheng Y; Li X; Manor LC; Cao H; Chen Q
    J Comput Biol; 2017 Sep; 24(9):942-952. PubMed ID: 28570130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genome-wide DNA methylation profiling integrated with gene expression profiling identifies
    Rani L; Mathur N; Gupta R; Gogia A; Kaur G; Dhanjal JK; Sundar D; Kumar L; Sharma A
    Clin Epigenetics; 2017; 9():57. PubMed ID: 28572861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative analysis of ZAP-70 expression and Ig VH mutational status in B-cell chronic lymphocytic leukemia.
    Muñoz L; Lasa A; Carricondo MT; Hernández C; Ubeda J; Nomdedéu JF
    Cytometry B Clin Cytom; 2007 Mar; 72(2):96-102. PubMed ID: 17051526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Morphologic identification of atypical chronic lymphocytic leukemia by digital microscopy.
    Marionneaux S; Maslak P; Keohane EM
    Int J Lab Hematol; 2014 Aug; 36(4):459-64. PubMed ID: 24400650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surrogate molecular markers for IGHV mutational status in chronic lymphocytic leukemia for predicting time to first treatment.
    Morabito F; Cutrona G; Mosca L; D'Anca M; Matis S; Gentile M; Vigna E; Colombo M; Recchia AG; Bossio S; De Stefano L; Maura F; Manzoni M; Ilariucci F; Consoli U; Vincelli I; Musolino C; Cortelezzi A; Molica S; Ferrarini M; Neri A
    Leuk Res; 2015 Aug; 39(8):840-5. PubMed ID: 26038121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic usage of V(H) gene mutation status and its surrogate markers and the role of antigen selection in chronic lymphocytic leukemia.
    Tobin G; Rosenquist R
    Med Oncol; 2005; 22(3):217-28. PubMed ID: 16110132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.